These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22890797)

  • 1. Evidence for distinct mechanisms of uptake and antitumor activity of secretory phospholipase A2 responsive liposome in prostate cancer.
    Mock JN; Costyn LJ; Wilding SL; Arnold RD; Cummings BS
    Integr Biol (Camb); 2013 Jan; 5(1):172-82. PubMed ID: 22890797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomes Targeting P21 Activated Kinase-1 (PAK-1) and Selective for Secretory Phospholipase A
    Najahi-Missaoui W; Quach ND; Somanath PR; Cummings BS
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the phospholipase A2 receptor in liposome drug delivery in prostate cancer cells.
    Quach ND; Mock JN; Scholpa NE; Eggert MW; Payré C; Lambeau G; Arnold RD; Cummings BS
    Mol Pharm; 2014 Oct; 11(10):3443-51. PubMed ID: 25189995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sterically stabilized liposomes targeting P21 (RAC1) activated kinase-1 and secreted phospholipase A
    Verma A; Najahi-Missaoui W; Cummings BS; Somanath PR
    Oncol Lett; 2020 Nov; 20(5):179. PubMed ID: 32934746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretory phospholipase A₂ responsive liposomes.
    Zhu G; Mock JN; Aljuffali I; Cummings BS; Arnold RD
    J Pharm Sci; 2011 Aug; 100(8):3146-3159. PubMed ID: 21455978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced intracellular uptake of sterically stabilized liposomal Doxorubicin in vitro resulting in improved antitumor activity in vivo.
    Xiong XB; Huang Y; Lu WL; Zhang H; Zhang X; Zhang Q
    Pharm Res; 2005 Jun; 22(6):933-9. PubMed ID: 15948037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue distribution and therapeutic effect of intravenous free or encapsulated liposomal doxorubicin on human prostate carcinoma xenografts.
    Vaage J; Barberá-Guillem E; Abra R; Huang A; Working P
    Cancer; 1994 Mar; 73(5):1478-84. PubMed ID: 8111716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of secretory phospholipases A2 in normal and malignant prostate cell lines: regulation by cytokines, cell signaling pathways, and epigenetic mechanisms.
    Menschikowski M; Hagelgans A; Gussakovsky E; Kostka H; Paley EL; Siegert G
    Neoplasia; 2008 Mar; 10(3):279-86. PubMed ID: 18320072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics, antitumor and cardioprotective effects of liposome-encapsulated phenylaminoethyl selenide in human prostate cancer rodent models.
    Kang JY; Eggert M; Mouli S; Aljuffali I; Fu X; Nie B; Sheil A; Waddey K; Oldham CD; May SW; Amin R; Arnold RD
    Pharm Res; 2015 Mar; 32(3):852-62. PubMed ID: 25158648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomes containing alkylated methotrexate analogues for phospholipase A(2) mediated tumor targeted drug delivery.
    Kaasgaard T; Andresen TL; Jensen SS; Holte RO; Jensen LT; Jørgensen K
    Chem Phys Lipids; 2009 Feb; 157(2):94-103. PubMed ID: 19094974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: in vitro and in vivo.
    Xiong XB; Huang Y; Lu WL; Zhang X; Zhang H; Nagai T; Zhang Q
    J Pharm Sci; 2005 Aug; 94(8):1782-93. PubMed ID: 15986461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic.
    Xiong XB; Huang Y; Lu WL; Zhang X; Zhang H; Nagai T; Zhang Q
    J Control Release; 2005 Oct; 107(2):262-75. PubMed ID: 16125816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound-Guided Delivery of siRNA and a Chemotherapeutic Drug by Using Microbubble Complexes: In Vitro and In Vivo Evaluations in a Prostate Cancer Model.
    Bae YJ; Yoon YI; Yoon TJ; Lee HJ
    Korean J Radiol; 2016; 17(4):497-508. PubMed ID: 27390541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic action of secreted phospholipase A2 in prostate cancer.
    Sved P; Scott KF; McLeod D; King NJ; Singh J; Tsatralis T; Nikolov B; Boulas J; Nallan L; Gelb MH; Sajinovic M; Graham GG; Russell PJ; Dong Q
    Cancer Res; 2004 Oct; 64(19):6934-40. PubMed ID: 15466184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RGD-based strategies for improving antitumor activity of paclitaxel-loaded liposomes in nude mice xenografted with human ovarian cancer.
    Zhao H; Wang JC; Sun QS; Luo CL; Zhang Q
    J Drug Target; 2009 Jan; 17(1):10-8. PubMed ID: 19016068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic study of the sPLA2-mediated hydrolysis of a thio-ester pro anticancer ether lipid.
    Linderoth L; Fristrup P; Hansen M; Melander F; Madsen R; Andresen TL; Peters GH
    J Am Chem Soc; 2009 Sep; 131(34):12193-200. PubMed ID: 19663381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genistein, a potent inhibitor of secretory phospholipase A2: a new insight in down regulation of inflammation.
    Dharmappa KK; Mohamed R; Shivaprasad HV; Vishwanath BS
    Inflammopharmacology; 2010 Feb; 18(1):25-31. PubMed ID: 19894024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo Evaluation of a Novel Estrogen-Targeted PEGylated Oxaliplatin Liposome for Gastric Cancer.
    Sun Y; Xie Y; Tang H; Ren Z; Luan X; Zhang Y; Zhu M; Lv Z; Bao H; Li Y; Liu R; Shen Y; Zheng Y; Pei J
    Int J Nanomedicine; 2021; 16():8279-8303. PubMed ID: 34992365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PSA-responsive and PSMA-mediated multifunctional liposomes for targeted therapy of prostate cancer.
    Xiang B; Dong DW; Shi NQ; Gao W; Yang ZZ; Cui Y; Cao DY; Qi XR
    Biomaterials; 2013 Sep; 34(28):6976-91. PubMed ID: 23777916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. iNGR-Modified Liposomes for Tumor Vascular Targeting and Tumor Tissue Penetrating Delivery in the Treatment of Glioblastoma.
    Zhou JE; Yu J; Gao L; Sun L; Peng T; Wang J; Zhu J; Lu W; Zhang L; Yan Z; Yu L
    Mol Pharm; 2017 May; 14(5):1811-1820. PubMed ID: 28388081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.